プロの翻訳者、企業、ウェブページから自由に利用できる翻訳レポジトリまで。
cimzia certolizumabpegol
cimzia certolizumab pegol
最終更新: 2017-04-26
使用頻度: 1
品質:
djelatna tvar je certolizumabpegol.
the active substance is certolizumab pegol.
最終更新: 2017-04-26
使用頻度: 1
品質:
ispitivanja karcinogenosti za certolizumabpegol nisu provedena.
carcinogenicity studies have not been performed with certolizumab pegol.
最終更新: 2017-04-26
使用頻度: 1
品質:
certolizumabpegol ne reagira križno s tnf-om glodavaca.
certolizumab pegol does not cross-react with rodent tnf.
最終更新: 2017-04-26
使用頻度: 1
品質:
cimzia 200 mg otopina za injekciji u napunjenoj brizgalici certolizumabpegol
cimzia 200 mg solution for injection in pre-filled pen certolizumab pegol
最終更新: 2017-04-26
使用頻度: 1
品質:
cimzia je otopina za ubrizgavanje koja sadrži djelatnu tvar certolizumabpegol.
cimzia is a solution for injection that contains the active substance certolizumab pegol.
最終更新: 2017-04-26
使用頻度: 1
品質:
prisutnost protutijela na certolizumabpegol uzrokovala je otprilike trostruko povećanje klirensa.
the presence of antibodies to certolizumab pegol resulted in an approximately three-fold increase in clearance.
最終更新: 2017-04-26
使用頻度: 1
品質:
inhibiranjem tnf-alfe, certolizumabpegol smanjuje upalu i druge simptome bolesti.
by blocking tnf-alpha, certolizumab pegol reduces the inflammation and other symptoms of the diseases.
最終更新: 2017-04-26
使用頻度: 1
品質:
certolizumabpegol dizajniran je za vezivanje na posrednički protein u tijelu faktor nekroze tumora alfa (tnf-alfa).
certolizumab pegol has been designed to attach to a messenger protein in the body called tumour necrosis factor alpha (tnf-alpha).
最終更新: 2017-04-26
使用頻度: 1
品質:
djelatna tvar lijeka cimzia, certolizumabpegol, je imunosupresiv, lijek koji smanjuje aktivnost imunosnog sustava (prirodne obrane tijela).
the active substance in cimzia, certolizumab pegol, is an immunosuppressant medicine, a medicine that reduces the activity of the immune system (the body’s natural defences).
最終更新: 2017-04-26
使用頻度: 1
品質:
certolizumabpegol je rekombinantni fab fragment humaniziranog protutijela protiv faktora nekroze tumora alfa (tnfα) eksprimiran u escherichiji coli i konjugiran s polietilenglikolom (peg).
certolizumab pegol is a recombinant, humanised antibody fab' fragment against tumour necrosis factor alpha (tnfα) expressed in escherichia coli and conjugated to polyethylene glycol (peg).
最終更新: 2017-04-26
使用頻度: 1
品質:
reaktivacija hepatitisa b pojavila se u bolesnika kroničnih nositelja tog virusa (tj. pozitivni na površinski antigen) koji su primali tnf-antagoniste, uključujući certolizumabpegol.
reactivation of hepatitis b has occurred in patients receiving a tnf-antagonist including certolizumab pegol, who are chronic carriers of this virus (i.e., surface antigen positive).
最終更新: 2017-04-26
使用頻度: 1
品質: